All treatments
Treatment
Ondexxya 200 mg powder for solution for infusion clinical trials
2 indexed studies · 0 currently recruiting
- AuthorisedTherapeutic use (Phase IV)
Weight-loss Effects aNd absorption of Direct oral anticoagulants in roux-en-Y gastric bypass patients: a prospective study (WENDY)
This study looks at how weight loss after stomach surgery (Roux-en-Y gastric bypass) affects a common blood thinning medicine called apixaban. Researchers will measure how much medicine is in the blood before and after surgery, and also track weight and any bleeding or blood clot issues.
For: Roux-en-Y gastric bypassNetherlands - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Randomized Study of Andexanet Alfa Compared to Usual Care in Patients Receiving a Factor Xa Inhibitor who Require Urgent Surgery or Procedure (ANNEXA-RS)
This study is comparing a new medication called Andexanet Alfa to usual care. It's for patients who are taking blood thinners (like apixaban, rivaroxaban, or edoxaban) and need urgent surgery. The aim is to see if Andexanet Alfa helps stop bleeding during their operation.
For: Reversal of anticoagulation effect in patients on a FXa inhibitor (apixaban · rivaroxaban · or edoxaban) who require urgent surgery or procedureFrance · Portugal · Spain